EU MDCG Issues Guidance on Post-Market Surveillance Under MDR, IVDR

The European Medical Device Coordination Group (MDCG) has released new guidance to aid manufacturers in complying with post-market surveillance requirements under the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR). The guidance provides detailed instruction on effective post-market surveillance activities, emphasizing the importance of continuous product monitoring to ensure safety and performance standards are met. Manufacturers are encouraged to integrate these surveillance activities into their quality management systems. This comprehensive document outlines the critical steps for setting up a robust surveillance process. It includes practical advice on developing post-market surveillance plans and reports, and highlights the need for manufacturers to proactively gather and analyze information on product performance. The MDCG stresses the importance of using data to detect and eliminate potential risks associated with medical devices in the market. Additionally, the new guidance focuses on fostering a culture of continuous improvement and patient safety within the industry. Manufacturers are urged to take a proactive approach in identifying trends and making evidence-based decisions to enhance device reliability. This initiative aligns with the EU’s commitment to maintaining high safety standards for medical devices and protecting public health. The MDCG’s guidance seeks to support manufacturers by clarifying regulatory expectations and offering tools to effectively manage post-market responsibilities. By adhering to these guidelines, companies can better meet compliance requirements and improve the overall quality and trustworthiness of their medical devices in the European market.\n\n